Supply Chain

Managing supplies is a crucial part of moving medical products from the manufacturer to patient’s bedside. Efficient supply chains can reduce healthcare costs and make medical devices more affordable for patients and health systems. This news page includes content on supply shortages, inventory management, and procurement practices.

RSS icon
Thumbnail

Private equity firm buys controlling stake in Surescripts

TPG will not own a majority of the e-prescriber, with CVS Health and Express Scripts maintaining a minority stake.

The Texas State Capital building in Austin where 140 scope creep bills were defeated in 2024 by the Texas medical Association.

Texas sues PBMs and drug manufacturers for insulin price collusion

Two weeks ago, the FTC launched a similar antitrust suit. The pharmacy benefit managers and pharmaceutical companies are accused of artificially raising drug costs through rebates and kickbacks.

money court scale of justice ruling legal settlement

BD settles majority of 38,000 lawsuits over dangerous surgical mesh

Becton Dickinson & Co does not admit to wrongdoing and said the undisclosed settlement will not significantly impact its bottom line.

Helene damage to bridge Baxter North Cove facility in North Carolina.

Baxter closes largest IV solution factory, sparking fears of a shortage

Flood damage forced Baxter to close a facility that makes 60% of IV solutions in the U.S., a loss of 1.5 million bags per day. 

FDA announces recall of Pfizer's fast-tracked sickle cell drug

The drugmaker is voluntarily withdrawing Oxbryta from the market due to a higher-than-acceptable risk of death.

the words "FDA recall" on a board

FDA announces Class I recall for compounding inlets due to risk of death

Baxter’s disposable inlets for automated compounding systems could pose a serious risk to patients if not properly inspected before use.

Federal Trade Comission FTC Sign logo

FTC sues PBMs and GPOs for insulin price collusion

In a statement announcing its lawsuit, the FTC said Caremark, Optum RX and Express Scripts benefit from manufacturer rebates and ignore lower-costing drugs as a way to artificially increase prices. 

FDA issues recall on infusion pump parts due to risk of uncontrollable drug flow

Due to a risk of fatal overdose, the recall is labeled as the most serious of its type. While no patients have died, two have reportedly been injured. 

Displaying 1 - 8 of 80
Design by Adaptive Theme